{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:38:12Z","timestamp":1775871492007,"version":"3.50.1"},"reference-count":219,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2&3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Major mental disorders, such as schizophrenia, bipolar disorder, and major depressive disorder, represent the leading cause of disability worldwide. Nevertheless, the current pharmacotherapy has several limitations, and a large portion of patients do not respond appropriately to it or remain with disabling symptoms overtime. Traditionally, pharmacological interventions for psychiatric disorders modulate dysfunctional neurotransmitter systems. In the last decades, compelling evidence has advocated for chronic inflammatory mechanisms underlying these disorders. Therefore, the repurposing of anti-inflammatory agents has emerged as an attractive therapeutic tool for mental disorders. Minocycline (MINO) and doxycycline (DOXY) are semisynthetic second-generation tetracyclines with neuroprotective and anti-inflammatory properties. More recently, the most promising results obtained in clinical trials using tetracyclines for major psychiatric disorders were for schizophrenia. In a reverse translational approach, tetracyclines inhibit microglial reactivity and toxic inflammation by mechanisms related to the inhibition of nuclear factor kappa B signaling, cyclooxygenase 2, and matrix metalloproteinases. However, the molecular mechanism underlying the effects of these tetracyclines is not fully understood. Therefore, the present review sought to summarize the latest findings of MINO and DOXY use for major psychiatric disorders and present the possible targets to their molecular and behavioral effects. In conclusion, tetracyclines hold great promise as (ready-to-use) agents for being used as adjunctive therapy for human neuropsychiatric disorders. Hence, the understanding of their molecular mechanisms may contribute to the discovery of new targets for the rational drug design of novel psychoactive agents.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000585","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T21:18:50Z","timestamp":1614374330000},"page":"123-141","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Tetracyclines, a promise for neuropsychiatric disorders: from adjunctive therapy to the discovery of new targets for rational drug design in psychiatry"],"prefix":"10.1097","volume":"32","author":[{"given":"Adriano Jos\u00e9 Maia","family":"Chaves Filho","sequence":"first","affiliation":[{"name":"Neuropharmacology Laboratory, Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Universidade Federal do Cear\u00e1, Fortaleza, CE"},{"name":"Laboratory for Molecular Modeling and Drug Design, LabMol, Faculdade de Farm\u00e1cia, Faculty of Pharmacy, Universidade Federal de Goi\u00e1s, Goi\u00e2nia, GO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melina","family":"Mottin","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Modeling and Drug Design, LabMol, Faculdade de Farm\u00e1cia, Faculty of Pharmacy, Universidade Federal de Goi\u00e1s, Goi\u00e2nia, GO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele Verde-Ramo","family":"Soares","sequence":"additional","affiliation":[{"name":"Neuropharmacology Laboratory, Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Universidade Federal do Cear\u00e1, Fortaleza, CE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma Marinho","family":"Juc\u00e1","sequence":"additional","affiliation":[{"name":"Neuropharmacology Laboratory, Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Universidade Federal do Cear\u00e1, Fortaleza, CE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina Horta","family":"Andrade","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Modeling and Drug Design, LabMol, Faculdade de Farm\u00e1cia, Faculty of Pharmacy, Universidade Federal de Goi\u00e1s, Goi\u00e2nia, GO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle S.","family":"Macedo","sequence":"additional","affiliation":[{"name":"Neuropharmacology Laboratory, Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Universidade Federal do Cear\u00e1, Fortaleza, CE"},{"name":"National Institute for Translational Medicine (INCT-TM, CNPq), Ribeir\u00e3o Preto, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/1570159X15666170828163048","article-title":"Therapeutic strategies for treatment of inflammation-related depression.","volume":"16","author":"Adzic","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tox.2007.11.003","article-title":"Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity.","volume":"244","author":"Ahuja","year":"2008","journal-title":"Toxicology"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"75954","DOI":"10.18632\/oncotarget.12488","article-title":"Doxycycline is an NF-\u03baB inhibitor that induces apoptotic cell death in malignant T-cells.","volume":"7","author":"Alexander-Savino","year":"2016","journal-title":"Oncotarget"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2017.03.003","article-title":"Minocycline reduces mechanical allodynia and depressive-like behaviour in type-1 diabetes mellitus in the rat.","volume":"327","author":"Amorim","year":"2017","journal-title":"Behav Brain Res"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neubiorev.2018.12.002","article-title":"Chronic unpredictable mild stress for modeling depression in rodents: meta-analysis of model reliability.","volume":"99","author":"Antoniuk","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pathophys.2007.02.001","article-title":"Matrix metalloproteinase-9 in spontaneously hypertensive hyperlipidemic rats.","volume":"15","author":"Asano","year":"2008","journal-title":"Pathophysiology"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(01)02437-1","article-title":"Glutamate neurotoxicity, oxidative stress and mitochondria.","volume":"497","author":"Atlante","year":"2001","journal-title":"FEBS Lett"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMp1500848","article-title":"The $2.6 billion pill\u2013methodologic and policy considerations.","volume":"372","author":"Avorn","year":"2015","journal-title":"N Engl J Med"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/ajp.2006.163.5.927","article-title":"Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia.","volume":"163","author":"Babulas","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/imm.12443","article-title":"Immune mechanisms linked to depression via oxidative stress and neuroprogression.","volume":"144","author":"Bakunina","year":"2015","journal-title":"Immunology"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2018.06.002","article-title":"Doxycycline counteracts neuroinflammation restoring memory in Alzheimer\u2019s disease mouse models.","volume":"70","author":"Balducci","year":"2018","journal-title":"Neurobiol Aging"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00210-012-0727-1","article-title":"Tetracyclines and pain.","volume":"385","author":"Bastos","year":"2012","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/nyas.13712","article-title":"Inflammation in psychiatric disorders: what comes first?","volume":"1437","author":"Bauer","year":"2019","journal-title":"Ann N Y Acad Sci"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainresbull.2018.02.007","article-title":"Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways.","volume":"139","author":"Ben-Azu","year":"2018","journal-title":"Brain Res Bull"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1741-7015-11-200","article-title":"So depression is an inflammatory disease, but where does the inflammation come from?","volume":"11","author":"Berk","year":"2013","journal-title":"BMC Med"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/jmg.2008.061796","article-title":"Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.","volume":"46","author":"Bilousova","year":"2009","journal-title":"J Med Genet"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0008-6363(01)00220-6","article-title":"Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells.","volume":"50","author":"Bond","year":"2001","journal-title":"Cardiovasc Res"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12640-009-9051-z","article-title":"Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons.","volume":"16","author":"Braidy","year":"2009","journal-title":"Neurotox Res"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archpsyc.61.8.774","article-title":"Serologic evidence of prenatal influenza in the etiology of schizophrenia.","volume":"61","author":"Brown","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1176\/appi.ajp.161.5.889","article-title":"Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring.","volume":"161","author":"Brown","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1176\/appi.ajp.162.4.767","article-title":"Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring.","volume":"162","author":"Brown","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbi.2008.09.007","article-title":"Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans.","volume":"23","author":"Brydon","year":"2009","journal-title":"Brain Behav Immun"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"1299833","DOI":"10.1080\/20016689.2017.1299833","article-title":"Filling the gap in CNS drug development: evaluation of the role of drug repurposing.","volume":"5","author":"Caban","year":"2017","journal-title":"J Mark Access Heal Policy"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"329418","DOI":"10.1155\/2015\/329418","article-title":"Anti-inflammatory properties of low and high doxycycline doses: an in vitro study.","volume":"2015","author":"Di Caprio","year":"2015","journal-title":"Mediators Inflamm"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/ene.13403","article-title":"Minocycline and matrix metalloproteinase inhibition in acute intracerebral hemorrhage: a pilot study.","volume":"24","author":"Chang","year":"2017","journal-title":"Eur J Neurol"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12035-013-8538-z","article-title":"Mmp-9 inhibition: a therapeutic strategy in ischemic stroke.","volume":"49","author":"Chaturvedi","year":"2014","journal-title":"Mol Neurobiol"},{"key":"R230-20250614","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/0269881112444941","article-title":"Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment.","volume":"26","author":"Chaudhry","year":"2012","journal-title":"J Psychopharmacol"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3109\/10715762.2012.674640","article-title":"Anti-apoptotic and anti-oxidative mechanisms of minocycline against sphingomyelinase\/ceramide neurotoxicity: implication in Alzheimer\u2019s disease and cerebral ischemia.","volume":"46","author":"Chen","year":"2012","journal-title":"Free Radic Res"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/0004867419835028","article-title":"Adjunctive use of anti-inflammatory drugs for schizophrenia: a meta- analytic investigation of randomized controlled trials.","volume":"53","author":"Cho","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/sj.npp.1301377","article-title":"Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer\u2019s disease models.","volume":"32","author":"Choi","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10637-006-9031-6","article-title":"A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas.","volume":"25","author":"Chu","year":"2007","journal-title":"Invest New Drugs"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fpsyt.2019.00125","article-title":"Leptin prevents lipopolysaccharide-induced depressive-like behaviors in mice: involvement of dopamine receptors.","volume":"10","author":"Cordeiro","year":"2019","journal-title":"Front Psychiatry"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour.","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0025-7125(16)31461-4","article-title":"The tetracyclines.","volume":"66","author":"Cunha","year":"1982","journal-title":"Med Clin North Am"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules.","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/0004867414533012","article-title":"Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries.","volume":"48","author":"Davis","year":"2014","journal-title":"Aust N Z J Psychiatry"},{"key":"R213-20250614","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2215-0366(18)30345-6","article-title":"The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial [published correction appears in Lancet Psychiatry. 2018 Nov 1].","volume":"5","author":"Deakin","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"R214-20250614","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/0004867417709357","article-title":"Adjunctive minocycline treatment for major depressive disorder: a proof of concept trial.","volume":"51","author":"Dean","year":"2017","journal-title":"Aust N Z J Psychiatry"},{"key":"R39-20250614","doi-asserted-by":"crossref","first-page":"180","DOI":"10.9758\/cpn.2014.12.3.180","article-title":"Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial.","volume":"12","author":"Dean","year":"2014","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jad.2017.07.053","article-title":"Antimanic activity of minocycline in a GBR12909-induced model of mania in mice: possible role of antioxidant and neurotrophic mechanisms.","volume":"225","author":"de Queiroz","year":"2018","journal-title":"J Affect Disord"},{"key":"R41-20250614","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMc1504317","article-title":"The cost of drug development.","volume":"372","author":"DiMasi","year":"2015","journal-title":"N Engl J Med"},{"key":"R42-20250614","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/cid\/cis457","article-title":"Does doxycycline protect against development of Clostridium difficile infection?","volume":"55","author":"Doernberg","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R43-20250614","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tips.2004.10.001","article-title":"Neuroprotection by tetracyclines.","volume":"25","author":"Domercq","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"R44-20250614","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression.","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol Psychiatry"},{"key":"R45-20250614","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3389\/fphar.2019.01247","article-title":"Minocycline ameliorates depressive-like behavior and demyelination induced by transient global cerebral ischemia by inhibiting microglial activation.","volume":"10","author":"Du","year":"2019","journal-title":"FRONT PHARMACOL"},{"key":"R46-20250614","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.intimp.2015.02.029","article-title":"Paroxetine differentially modulates LPS-induced TNF\u03b1 and IL-6 production in mouse macrophages.","volume":"25","author":"Durairaj","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"R47-20250614","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/jphp.12815","article-title":"Drug repurposing may generate novel approaches to treating depression.","volume":"69","author":"Ebada","year":"2017","journal-title":"J Pharm Pharmacol"},{"key":"R48-20250614","doi-asserted-by":"crossref","first-page":"e57827","DOI":"10.1371\/journal.pone.0057827","article-title":"COL-3, a chemically modified tetracycline, inhibits lipopolysaccharide-induced microglia activation and cytokine expression in the brain.","volume":"8","author":"Edan","year":"2013","journal-title":"PLoS One"},{"key":"R49-20250614","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2015.10.024","article-title":"Minocycline attenuates A\u03b2 oligomers-induced pro-inflammatory phenotype in primary microglia while enhancing A\u03b2 fibrils phagocytosis.","volume":"609","author":"El-Shimy","year":"2015","journal-title":"Neurosci Lett"},{"key":"R50-20250614","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.schres.2010.05.014","article-title":"Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8.","volume":"121","author":"Ellman","year":"2010","journal-title":"Schizophr Res"},{"key":"R51-20250614","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/YIC.0000000000000098","article-title":"Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial.","volume":"31","author":"Emadi-Kouchak","year":"2016","journal-title":"Int Clin Psychopharmacol"},{"key":"R52-20250614","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.neuropharm.2011.01.011","article-title":"The viral theory of schizophrenia revisited: abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring.","volume":"62","author":"Fatemi","year":"2012","journal-title":"Neuropharmacology"},{"key":"R53-20250614","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/wps.20481","article-title":"The promise and challenges of drug repurposing in psychiatry.","volume":"17","author":"Fava","year":"2018","journal-title":"World Psychiatry"},{"key":"R54-20250614","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.","volume":"246","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"key":"R55-20250614","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/npp.2013.115","article-title":"Chronic interferon-\u03b1 decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.","volume":"38","author":"Felger","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"R56-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2013.02.004","article-title":"Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger.","volume":"33","author":"Frank","year":"2013","journal-title":"Brain Behav Immun"},{"key":"R57-20250614","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881113512909","article-title":"Reviewing the ketamine model for schizophrenia.","volume":"28","author":"Frohlich","year":"2014","journal-title":"J Psychopharmacol"},{"key":"R58-20250614","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.pnpbp.2007.08.031","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline.","volume":"32","author":"Fujita","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R59-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics1010001","article-title":"Classification framework and chemical biology of tetracycline-structure-based drugs.","volume":"1","author":"Fuoco","year":"2012","journal-title":"Antibiotics (Basel)"},{"key":"R60-20250614","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.schres.2018.07.019","article-title":"Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: new data and an updated meta-analysis.","volume":"202","author":"Gallego","year":"2018","journal-title":"Schizophr Res"},{"key":"R215-20250614","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/1872213X08666141029123524","article-title":"Minocycline as add-on treatment decreases the negative symptoms of schizophrenia; a randomized placebo-controlled clinical trial.","volume":"8","author":"Ghanizadeh","year":"2014","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"R61-20250614","doi-asserted-by":"crossref","first-page":"e772","DOI":"10.1038\/tp.2016.38","article-title":"Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia.","volume":"6","author":"Giovanoli","year":"2016","journal-title":"Transl Psychiatry"},{"key":"R62-20250614","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol Psychiatry"},{"key":"R63-20250614","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1111\/j.1460-9568.2007.05873.x","article-title":"Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca(2+) signalling in hippocampal neurons.","volume":"26","author":"Gonz\u00e1lez","year":"2007","journal-title":"Eur J Neurosci"},{"key":"R64-20250614","doi-asserted-by":"crossref","first-page":"C539","DOI":"10.1152\/ajpcell.00047.2010","article-title":"Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature.","volume":"299","author":"Griffin","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"R65-20250614","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.4049\/jimmunol.1600436","article-title":"Impact of minocycline on extracellular matrix metalloproteinase inducer, a factor implicated in multiple sclerosis immunopathogenesis.","volume":"197","author":"Hahn","year":"2016","journal-title":"J Immunol"},{"key":"R66-20250614","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.psyneuen.2019.04.021","article-title":"Minocycline inhibits microglial activation and alleviates depressive-like behaviors in male adolescent mice subjected to maternal separation.","volume":"107","author":"Han","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"R67-20250614","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1038\/tp.2014.31","article-title":"Modulation of early stress-induced neurobiological changes: a review of behavioural and pharmacological interventions in animal models.","volume":"4","author":"Harrison","year":"2014","journal-title":"Transl Psychiatry"},{"key":"R68-20250614","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-5-15","article-title":"Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia.","volume":"5","author":"Henry","year":"2008","journal-title":"J Neuroinflammation"},{"key":"R69-20250614","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/cercor\/bhs151","article-title":"Chronic stress induced remodeling of the prefrontal cortex: structural re-organization of microglia and the inhibitory effect of minocycline.","volume":"23","author":"Hinwood","year":"2013","journal-title":"Cereb Cortex"},{"key":"R70-20250614","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biopsych.2017.08.005","article-title":"Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: a positron emission tomography study.","volume":"83","author":"Holmes","year":"2018","journal-title":"Biol Psychiatry"},{"key":"R71-20250614","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-015-0203-5","article-title":"Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis.","volume":"3","author":"Holtman","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"R72-20250614","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.4103\/1673-5374.135318","article-title":"High matrix metalloproteinase-9 expression induces angiogenesis and basement membrane degradation in stroke-prone spontaneously hypertensive rats after cerebral infarction.","volume":"9","author":"Hou","year":"2014","journal-title":"Neural Regen Res"},{"key":"R73-20250614","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.euroneuro.2014.05.011","article-title":"Effects of prenatal hypoxia on schizophrenia-related phenotypes in heterozygous reeler mice: a gene \u00d7 environment interaction study.","volume":"24","author":"Howell","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"R74-20250614","first-page":"1","article-title":"Detection of functional matrix metalloproteinases by zymography.","volume":"45","author":"Hu","year":"2010","journal-title":"J Vis Exp"},{"key":"R216-20250614","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1177\/0269881117724352","article-title":"Minocycline as an adjunct for treatment-resistant depressive symptoms: a pilot randomised placebo-controlled trial.","volume":"31","author":"Husain","year":"2017","journal-title":"J Psychopharmacol"},{"key":"R75-20250614","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s13063-015-0933-5","article-title":"Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial.","volume":"16","author":"Husain","year":"2015","journal-title":"Trials"},{"key":"R76-20250614","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neures.2009.03.015","article-title":"Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood.","volume":"64","author":"Ibi","year":"2009","journal-title":"Neurosci Res"},{"key":"R77-20250614","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00406-015-0649-2","article-title":"Minocycline exacerbates apoptotic neurodegeneration induced by the NMDA receptor antagonist MK-801 in the early postnatal mouse brain.","volume":"266","author":"Inta","year":"2016","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R78-20250614","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1128\/JVI.00323-07","article-title":"Therapy with minocycline aggravates experimental rabies in mice.","volume":"81","author":"Jackson","year":"2007","journal-title":"J Virol"},{"key":"R79-20250614","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/sj.jcbfm.9600025","article-title":"Doxycycline reduces cleaved caspase-3 and microglial activation in an animal model of neonatal hypoxia-ischemia.","volume":"25","author":"Jantzie","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"key":"R80-20250614","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1503\/jpn.090061","article-title":"Doxycycline inhibits proinflammatory cytokines but not acute cerebral cytogenesis after hypoxia-ischemia in neonatal rats.","volume":"35","author":"Jantzie","year":"2010","journal-title":"J Psychiatry Neurosci"},{"key":"R81-20250614","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0736-5748(97)00029-4","article-title":"Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro.","volume":"15","author":"Jarskog","year":"1997","journal-title":"Int J Dev Neurosci"},{"key":"R82-20250614","doi-asserted-by":"crossref","first-page":"E06","DOI":"10.1176\/appi.neuropsych.11120376","article-title":"Successful use of add-on minocycline for treatment of persistent negative symptoms in schizophrenia.","volume":"25","author":"Jhamnani","year":"2013","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R83-20250614","first-page":"167","article-title":"Molecular similarity: a basis for designing drug screening programs.","volume":"291","author":"Johnson","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"R84-20250614","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.1998.tb09556.x","article-title":"Administration of interleukin-1 at birth affects dopaminergic neurons in adult mice.","volume":"840","author":"Kabiersch","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"R85-20250614","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/cid\/cix013","article-title":"Effectiveness of long-term doxycycline treatment and cognitive-behavioral therapy on fatigue severity in patients with Q fever fatigue syndrome (Qure study): a randomized controlled trial.","volume":"64","author":"Keijmel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R250-20250614","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/JCP.0000000000000345","article-title":"Adjunctive minocycline in clozapine-treated schizophrenia patients with persistent symptoms.","volume":"35","author":"Kelly","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"R86-20250614","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.schres.2011.08.005","article-title":"Adjunct minocycline to clozapine treated patients with persistent schizophrenia symptoms.","volume":"133","author":"Kelly","year":"2011","journal-title":"Schizophr Res"},{"key":"R87-20250614","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","article-title":"Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study.","volume":"71","author":"Khandaker","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"R88-20250614","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","article-title":"Minocycline and neurodegenerative diseases.","volume":"196","author":"Kim","year":"2009","journal-title":"Behav Brain Res"},{"key":"R89-20250614","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF02980066","article-title":"Inhibitory action of minocycline on lipopolysaccharide-induced release of nitric oxide and prostaglandin E2 in BV2 microglial cells.","volume":"27","author":"Kim","year":"2004","journal-title":"Arch Pharm Res"},{"key":"R90-20250614","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.biopsych.2006.09.033","article-title":"Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A.","volume":"62","author":"Kling","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R91-20250614","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1038\/cddis.2013.54","article-title":"Minocycline selectively inhibits M1 polarization of microglia.","volume":"4","author":"Kobayashi","year":"2013","journal-title":"Cell Death Dis"},{"key":"R92-20250614","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0269881117711708","article-title":"Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.","volume":"31","author":"Kopschina Feltes","year":"2017","journal-title":"J Psychopharmacol"},{"key":"R93-20250614","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1471-4159.2005.03219.x","article-title":"Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity.","volume":"94","author":"Kraus","year":"2005","journal-title":"J Neurochem"},{"key":"R94-20250614","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/15622971003653246","article-title":"The association of infectious agents and schizophrenia.","volume":"11","author":"Krause","year":"2010","journal-title":"World J Biol Psychiatry"},{"key":"R95-20250614","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2013.10.057","article-title":"Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington\u2019s disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences.","volume":"720","author":"Kumar","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"R96-20250614","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3109\/00207454.2013.872102","article-title":"The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke.","volume":"124","author":"Kurzepa","year":"2014","journal-title":"Int J Neurosci"},{"key":"R97-20250614","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/bph.13364","article-title":"Microglial activation and progressive brain changes in schizophrenia.","volume":"173","author":"Laskaris","year":"2016","journal-title":"Br J Pharmacol"},{"key":"R98-20250614","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/glia.22496","article-title":"Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model.","volume":"61","author":"Lazzarini","year":"2013","journal-title":"Glia"},{"key":"R99-20250614","doi-asserted-by":"crossref","first-page":"6378137","DOI":"10.1155\/2016\/6378137","article-title":"Drug repurposing is a new opportunity for developing drugs against neuropsychiatric disorders.","volume":"2016","author":"Lee","year":"2016","journal-title":"Schizophr Res Treatment"},{"key":"R100-20250614","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1742-2094-6-13","article-title":"Neuroinflammation and MMPs: potential therapeutic targets in neonatal hypoxic-ischemic injury.","volume":"6","author":"Leonardo","year":"2009","journal-title":"J Neuroinflammation"},{"key":"R101-20250614","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainres.2007.03.080","article-title":"Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia.","volume":"1154","author":"Levkovitz","year":"2007","journal-title":"Brain Res"},{"key":"R102-20250614","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00406-004-0481-6","article-title":"Antibodies to infectious agents in individuals with recent onset schizophrenia.","volume":"254","author":"Leweke","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R103-20250614","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1007\/s12035-015-9318-8","article-title":"Minocycline protects against NLRP3 inflammasome-induced inflammation and P53-associated apoptosis in early brain injury after subarachnoid hemorrhage.","volume":"53","author":"Li","year":"2016","journal-title":"Mol Neurobiol"},{"key":"R104-20250614","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pnpbp.2013.12.017","article-title":"Minocycline improves recognition memory and attenuates microglial activation in Gunn rat: a possible hyperbilirubinemia-induced animal model of schizophrenia.","volume":"50","author":"Liaury","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R105-20250614","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1742-2094-9-56","article-title":"Morphological features of microglial cells in the hippocampal dentate gyrus of Gunn rat: a possible schizophrenia animal model.","volume":"9","author":"Liaury","year":"2012","journal-title":"J Neuroinflammation"},{"key":"R106-20250614","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(01)02324-2","article-title":"Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons.","volume":"315","author":"Lin","year":"2001","journal-title":"Neurosci Lett"},{"key":"R107-20250614","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1161\/CIRCULATIONAHA.108.806505","article-title":"Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells.","volume":"119","author":"Lindeman","year":"2009","journal-title":"Circulation"},{"key":"R108-20250614","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/exnr.1998.6715","article-title":"Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines.","volume":"149","author":"Ling","year":"1998","journal-title":"Exp Neurol"},{"key":"R109-20250614","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.archoralbio.2012.12.009","article-title":"Toll-like receptor activation and mechanical force stimulation promote the secretion of matrix metalloproteinases 1, 3 and 10 of human periodontal fibroblasts via p38, JNK and NF-kB.","volume":"58","author":"Lisboa","year":"2013","journal-title":"Arch Oral Biol"},{"key":"R217-20250614","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.schres.2014.01.011","article-title":"Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: a double blind, randomized, controlled trial.","volume":"153","author":"Liu","year":"2014","journal-title":"Schizophr Res"},{"key":"R110-20250614","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainresbull.2018.08.015","article-title":"Chronic minocycline treatment reduces the anxiety-like behaviors induced by repeated restraint stress through modulating neuroinflammation.","volume":"143","author":"Liu","year":"2018","journal-title":"Brain Res Bull"},{"key":"R111-20250614","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000452172","article-title":"Minocycline suppresses NLRP3 inflammasome activation in experimental ischemic stroke.","volume":"23","author":"Lu","year":"2016","journal-title":"Neuroimmunomodulation"},{"key":"R112-20250614","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/bies.201100024","article-title":"Probiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probiotics.","volume":"33","author":"Lyte","year":"2011","journal-title":"Bioessays"},{"key":"R113-20250614","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1590\/S0100-879X2012007500031","article-title":"Animal models of prenatal immune challenge and their contribution to the study of schizophrenia: a systematic review.","volume":"45","author":"Mac\u00eado","year":"2012","journal-title":"Brazilian J Med Biol Res"},{"key":"R114-20250614","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2202-7-56","article-title":"Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke.","volume":"7","author":"Machado","year":"2006","journal-title":"BMC Neurosci"},{"key":"R115-20250614","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0278-5846(94)00101-M","article-title":"Evidence for an immune response in major depression: a review and hypothesis.","volume":"19","author":"Maes","year":"1995","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R116-20250614","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","article-title":"A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.","volume":"35","author":"Maes","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R117-20250614","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1600-0447.2012.01908.x","article-title":"In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes.","volume":"127","author":"Maes","year":"2013","journal-title":"Acta Psychiatr Scand"},{"key":"R118-20250614","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jad.2013.03.029","article-title":"In myalgic encephalomyelitis\/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.","volume":"150","author":"Maes","year":"2013","journal-title":"J Affect Disord"},{"key":"R120-20250614","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/cid\/cis1022","article-title":"Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial.","volume":"56","author":"Manhart","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R121-20250614","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.ATV.0000058404.92759.32","article-title":"Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.","volume":"23","author":"Manning","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R122-20250614","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1089\/ars.2009.2695","article-title":"Mitochondrial glutathione, a key survival antioxidant.","volume":"11","author":"Mar\u00ed","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"R123-20250614","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41389-017-0009-3","article-title":"Doxycycline induces apoptosis via ER stress selectively to cells with a cancer stem cell-like properties: importance of stem cell plasticity.","volume":"6","author":"Matsumoto","year":"2017","journal-title":"Oncogenesis"},{"key":"R124-20250614","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbi.2014.01.019","article-title":"Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia.","volume":"38","author":"Mattei","year":"2014","journal-title":"Brain Behav Immun"},{"key":"R125-20250614","doi-asserted-by":"crossref","first-page":"e1120","DOI":"10.1038\/tp.2017.80","article-title":"Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment.","volume":"7","author":"Mattei","year":"2017","journal-title":"Transl Psychiatry"},{"key":"R126-20250614","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.bbamcr.2017.04.011","article-title":"Selective small-molecule inhibitors as chemical tools to define the roles of matrix metalloproteinases in disease.","volume":"1864","author":"Meisel","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"R127-20250614","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00006123-200106000-00051","article-title":"Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction.","volume":"48","author":"Mejia","year":"2001","journal-title":"Neurosurgery"},{"key":"R128-20250614","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jpsychires.2013.06.008","article-title":"Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration.","volume":"47","author":"Mello","year":"2013","journal-title":"J Psychiatr Res"},{"key":"R129-20250614","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.biopsych.2013.07.011","article-title":"Prenatal Poly(I:C) exposure and other developmental immune activation models in rodent systems.","volume":"75","author":"Meyer","year":"2014","journal-title":"Biol Psychiatry"},{"key":"R130-20250614","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-009-1504-9","article-title":"Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia.","volume":"206","author":"Meyer","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"R131-20250614","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neubiorev.2004.10.012","article-title":"Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia.","volume":"29","author":"Meyer","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"R132-20250614","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.","volume":"65","author":"Miller","year":"2009","journal-title":"Biol Psychiatry"},{"key":"R133-20250614","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pnpbp.2012.02.002","article-title":"Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study.","volume":"37","author":"Miyaoka","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R134-20250614","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2710.2009.01073.x","article-title":"Doxycycline vs. levofloxacin in the treatment of community-acquired pneumonia.","volume":"35","author":"Mokabberi","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"R135-20250614","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3389\/fpsyt.2019.00892","article-title":"Cytokine alterations in schizophrenia: an updated review.","volume":"10","author":"Momtazmanesh","year":"2019","journal-title":"Front Psychiatry"},{"key":"R136-20250614","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/0269881119875979","article-title":"Sex influences in the preventive effects of N-acetylcysteine in a two-hit animal model of schizophrenia.","volume":"34","author":"Monte","year":"2020","journal-title":"J Psychopharmacol"},{"key":"R137-20250614","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1177\/0269881113503506","article-title":"Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: possible involvement of antioxidant and nitrergic pathways.","volume":"27","author":"Monte","year":"2013","journal-title":"J Psychopharmacol"},{"key":"R138-20250614","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2005.02.062","article-title":"Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage.","volume":"1044","author":"Morimoto","year":"2005","journal-title":"Brain Res"},{"key":"R139-20250614","first-page":"877","article-title":"New drugs cost US$2.6 billion to develop.","volume":"13","author":"Mullard","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"R140-20250614","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/schbul\/sby024","article-title":"Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations.","volume":"44","author":"M\u00fcller","year":"2018","journal-title":"Schizophr Bull"},{"key":"R141-20250614","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0920-9964(94)00045-A","article-title":"Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology.","volume":"14","author":"M\u00fcller","year":"1995","journal-title":"Schizophr Res"},{"key":"R142-20250614","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jad.2017.12.067","article-title":"A pilot study of minocycline for the treatment of bipolar depression: effects on cortical glutathione and oxidative stress in vivo.","volume":"230","author":"Murrough","year":"2018","journal-title":"J Affect Disord"},{"key":"R143-20250614","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.brainres.2007.10.052","article-title":"Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase.","volume":"1188","author":"Nagel","year":"2008","journal-title":"Brain Res"},{"key":"R144-20250614","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.imbio.2016.07.001","article-title":"The role of macrophages in anti-inflammatory activity of antidepressant drugs.","volume":"222","author":"Nazimek","year":"2017","journal-title":"Immunobiology"},{"key":"R145-20250614","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/j.1471-4159.2007.04889.x","article-title":"Minocycline decreases in vitro microglial motility, beta1-integrin, and Kv1.3 channel expression.","volume":"103","author":"Nutile-McMenemy","year":"2007","journal-title":"J Neurochem"},{"key":"R146-20250614","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.","volume":"14","author":"O\u2019Connor","year":"2009","journal-title":"MOL PSYCHIATRY"},{"key":"R147-20250614","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/acps.12978","article-title":"Leaky gut biomarkers in depression and suicidal behavior.","volume":"139","author":"Ohlsson","year":"2019","journal-title":"Acta Psychiatr Scand"},{"key":"R148-20250614","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1208\/s12248-012-9390-1","article-title":"Drug repurposing: far beyond new targets for old drugs.","volume":"14","author":"Oprea","year":"2012","journal-title":"AAPS J"},{"key":"R149-20250614","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling.","volume":"8","author":"Page-McCaw","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R150-20250614","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00775-008-0395-2","article-title":"Specific binding of divalent metal ions to tetracycline and to the Tet repressor\/tetracycline complex.","volume":"13","author":"Palm","year":"2008","journal-title":"J Biol Inorg Chem"},{"key":"R151-20250614","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1176\/appi.ajp.2011.10091351","article-title":"Toxoplasma infection and later development of schizophrenia in mothers.","volume":"168","author":"Pedersen","year":"2011","journal-title":"Am J Psychiatry"},{"key":"R152-20250614","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1471-4159.2004.02796.x","article-title":"Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways.","volume":"91","author":"Pi","year":"2004","journal-title":"J Neurochem"},{"key":"R153-20250614","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1189\/jlb.1006629","article-title":"Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins.","volume":"81","author":"Piccard","year":"2007","journal-title":"J Leukoc Biol"},{"key":"R154-20250614","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1600-051X.2004.00558.x","article-title":"Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. A review.","volume":"31","author":"Preshaw","year":"2004","journal-title":"J Clin Periodontol"},{"key":"R155-20250614","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.brainres.2006.03.104","article-title":"Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson\u2019s disease.","volume":"1093","author":"Quintero","year":"2006","journal-title":"Brain Res"},{"key":"R156-20250614","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/0269881114527358","article-title":"Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia.","volume":"28","author":"Qurashi","year":"2014","journal-title":"J Psychopharmacol"},{"key":"R157-20250614","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jpsychores.2018.11.007","article-title":"Long-term effect of cognitive behavioural therapy and doxycycline treatment for patients with Q fever fatigue syndrome: one-year follow-up of the Qure study.","volume":"116","author":"Raijmakers","year":"2019","journal-title":"J Psychosom Res"},{"key":"R158-20250614","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1023\/A:1020546615229","article-title":"TNF-induced signaling in apoptosis.","volume":"19","author":"Rath","year":"1999","journal-title":"J Clin Immunol"},{"key":"R159-20250614","doi-asserted-by":"crossref","first-page":"e000615","DOI":"10.1136\/esmoopen-2019-000615","article-title":"Old drug, new clinical use, no man\u2019s land for the indication: an awareness call from European experts.","volume":"5","author":"Rauh","year":"2020","journal-title":"ESMO Open"},{"key":"R160-20250614","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0271678X16655551","article-title":"Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers.","volume":"36","author":"Rempe","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"R161-20250614","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11011-014-9602-8","article-title":"Minocycline protects against oxidative damage and alters energy metabolism parameters in the brain of rats subjected to chronic mild stress.","volume":"30","author":"R\u00e9us","year":"2015","journal-title":"Metab Brain Dis"},{"key":"R162-20250614","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.schres.2013.10.040","article-title":"Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine.","volume":"151","author":"Ribeiro","year":"2013","journal-title":"Schizophr Res"},{"key":"R163-20250614","first-page":"1000276","article-title":"Depression correlates with increased plasma levels of inflammatory cytokines and a dysregulated oxidant\/antioxidant balance in HIV-1-infected subjects undergoing antiretroviral therapy.","volume":"5","author":"Rivera-Rivera","year":"2014","journal-title":"J Clin Cell Immunol"},{"key":"R164-20250614","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","article-title":"Inflamed moods: a review of the interactions between inflammation and mood disorders.","volume":"53","author":"Rosenblat","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R165-20250614","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jad.2017.10.042","article-title":"Efficacy and tolerability of minocycline for depression: a systematic review and meta-analysis of clinical trials.","volume":"227","author":"Rosenblat","year":"2018","journal-title":"J Affect Disord"},{"key":"R166-20250614","doi-asserted-by":"crossref","first-page":"BSR20171420","DOI":"10.1042\/BSR20171420","article-title":"IL-12-mediated transcriptional regulation of matrix metalloproteinases.","volume":"38","author":"Roupakia","year":"2018","journal-title":"Biosci Rep"},{"key":"R167-20250614","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11011-015-9764-z","article-title":"On the effect of minocycline on the depressive-like behavior of mice repeatedly exposed to malathion: interaction between nitric oxide and cholinergic system.","volume":"31","author":"Saeedi Saravi","year":"2016","journal-title":"Metab Brain Dis"},{"key":"R168-20250614","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12958-019-0481-z","article-title":"Doxycycline reduces MMP-2 activity and inhibits invasion of 12Z epithelial endometriotic cells as well as MMP-2 and -9 activity in primary endometriotic stromal cells in vitro.","volume":"17","author":"Samartzis","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"R169-20250614","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12640-015-9592-2","article-title":"Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways.","volume":"29","author":"Santa-Cec\u00edlia","year":"2016","journal-title":"NEUROTOX RES"},{"key":"R170-20250614","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/bcpt.12489","article-title":"Minocycline attenuates depressive-like behaviour induced by rat model of testicular torsion: involvement of nitric oxide pathway.","volume":"118","author":"Saravi","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R171-20250614","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-017-0073-7","article-title":"Treatment of bipolar depression with minocycline and\/or aspirin: an adaptive, 2\u00d72 double-blind, randomized, placebo-controlled, phase IIA clinical trial.","volume":"8","author":"Savitz","year":"2018","journal-title":"Transl Psychiatry"},{"key":"R172-20250614","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fonc.2018.00452","article-title":"Doxycycline, an inhibitor of mitochondrial biogenesis, effectively reduces cancer stem cells (CSCs) in early breast cancer patients: a clinical pilot study.","volume":"8","author":"Scatena","year":"2018","journal-title":"Front Oncol"},{"key":"R173-20250614","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","article-title":"Cytokines and major depression.","volume":"29","author":"Schiepers","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R174-20250614","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12974-015-0431-4","article-title":"Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration.","volume":"12","author":"Scholz","year":"2015","journal-title":"J Neuroinflammation"},{"key":"R175-20250614","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S2215-0366(18)30048-8","article-title":"Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study.","volume":"5","author":"Setiawan","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"R218-20250614","first-page":"157","article-title":"The role for oxidative stress in neurodegenerative diseases [in Japanese].","volume":"60","author":"Shibata","year":"2008","journal-title":"Brain Nerve"},{"key":"R177-20250614","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/3-211-30714-1_29","article-title":"Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats.","volume":"96","author":"Shigemori","year":"2006","journal-title":"Acta Neurochir Suppl"},{"key":"R178-20250614","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","article-title":"Safety of doxycycline and minocycline: a systematic review.","volume":"27","author":"Smith","year":"2005","journal-title":"Clin Ther"},{"key":"R179-20250614","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1523\/JNEUROSCI.2178-07.2007","article-title":"Maternal immune activation alters fetal brain development through interleukin-6.","volume":"27","author":"Smith","year":"2007","journal-title":"J Neurosci"},{"key":"R180-20250614","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/bdi.12496","article-title":"A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I\/II depression.","volume":"19","author":"Soczynska","year":"2017","journal-title":"Bipolar Disord"},{"key":"R181-20250614","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S1092852916000638","article-title":"Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia.","volume":"22","author":"Solmi","year":"2017","journal-title":"CNS Spectr"},{"key":"R182-20250614","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0029-1202263","article-title":"Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment.","volume":"42","author":"Song","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"R219-20250614","first-page":"529","article-title":"Effect of minocycline on negative symptoms in patients with schizophrenia and its influence on tumor necrosis factor-\u03b1 [In Chinese].","volume":"35","author":"Song","year":"2017","journal-title":"Herald Med"},{"key":"R183-20250614","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0006-3223(03)00566-3","article-title":"Depression and cancer: mechanisms and disease progression.","volume":"54","author":"Spiegel","year":"2003","journal-title":"Biol Psychiatry"},{"key":"R184-20250614","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/1099800409346333","article-title":"The role of doxycycline as a matrix metalloproteinase inhibitor for the treatment of chronic wounds.","volume":"11","author":"Stechmiller","year":"2010","journal-title":"Biol Res Nurs"},{"key":"R185-20250614","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gutjnl-2017-314759","article-title":"Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression.","volume":"67","author":"Stevens","year":"2018","journal-title":"Gut"},{"key":"R186-20250614","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.neubiorev.2011.10.001","article-title":"Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity.","volume":"36","author":"Stuart","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"R187-20250614","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00005-019-00543-8","article-title":"The influence of antidepressants on the immune system.","volume":"67","author":"Sza\u0142ach","year":"2019","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"R7-20250614","article-title":"Tetracycline: classification, structure activity relationship and mechanism of action as a theranostic agent for infectious lesions-a mini review.","author":"Tariq","year":"2018","journal-title":"Biomed J Sci Tech Res"},{"key":"R188-20250614","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jad.2020.03.022","article-title":"Antidepressants of different classes cause distinct behavioral and brain pro- and anti-inflammatory changes in mice submitted to an inflammatory model of depression.","volume":"268","author":"Tomaz","year":"2020","journal-title":"J Affect Disord"},{"key":"R189-20250614","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajp.2012.09.007","article-title":"The effects of antipsychotics on behavioral abnormalities of the Gunn rat (unconjugated hyperbilirubinemia rat), a rat model of schizophrenia.","volume":"6","author":"Tsuchie","year":"2013","journal-title":"Asian J Psychiatr"},{"key":"R190-20250614","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/hr.2009.26","article-title":"The expression of matrix metalloproteinase-13 is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.","volume":"32","author":"Ueno","year":"2009","journal-title":"Hypertens Res"},{"key":"R191-20250614","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-9-20","article-title":"Altered microglial response to A\u03b2 plaques in APPPS1-21 mice heterozygous for TREM2.","volume":"9","author":"Ulrich","year":"2014","journal-title":"Mol Neurodegener"},{"key":"R192-20250614","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1743-422X-9-174","article-title":"The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review.","volume":"9","author":"Vassallo","year":"2012","journal-title":"Virol J"},{"key":"R193-20250614","first-page":"520","article-title":"Tetraciclinas, sulfamidas y metronidazol.","volume":"21","author":"Vicente","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R194-20250614","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1101\/gad.815400","article-title":"Matrix metalloproteinases: effectors of development and normal physiology.","volume":"14","author":"Vu","year":"2000","journal-title":"Genes Dev"},{"key":"R195-20250614","doi-asserted-by":"crossref","first-page":"19948","DOI":"10.1074\/jbc.M313629200","article-title":"Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria.","volume":"279","author":"Wang","year":"2004","journal-title":"J Biol Chem"},{"key":"R196-20250614","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.02.021","article-title":"Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: a systematic review and meta-analysis.","volume":"79","author":"Wang","year":"2019","journal-title":"Brain Behav Immun"},{"key":"R197-20250614","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41593-019-0343-1","article-title":"Microglia, complement and schizophrenia.","volume":"22","author":"Wang","year":"2019","journal-title":"Nat Neurosci"},{"key":"R198-20250614","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.1832501100","article-title":"Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington\u2019s disease.","volume":"100","author":"Wang","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R199-20250614","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12974-018-1054-3","article-title":"Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats.","volume":"15","author":"Wang","year":"2018","journal-title":"J Neuroinflammation"},{"key":"R220-20250614","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.schres.2018.10.023","article-title":"The effect of minocycline on symptoms in schizophrenia: results from a randomized controlled trial.","volume":"206","author":"Weiser","year":"2019","journal-title":"Schizophr Res"},{"key":"R200-20250614","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1460-9568.2012.08114.x","article-title":"Doxycycline treatment in a neonatal rat model of hypoxia-ischemia reduces cerebral tissue and white matter injury: a longitudinal magnetic resonance imaging study.","volume":"36","author":"Wider\u00f8e","year":"2012","journal-title":"Eur J Neurosci"},{"key":"R201-20250614","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","article-title":"The chronic mild stress (CMS) model of depression: history, evaluation and usage.","volume":"6","author":"Willner","year":"2017","journal-title":"Neurobiol Stress"},{"key":"R202-20250614","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S1461145708009206","article-title":"Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia.","volume":"12","author":"Winter","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"R203-20250614","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.euroneuro.2016.11.012","article-title":"Adjunctive minocycline for schizophrenia: a meta-analysis of randomized controlled trials.","volume":"27","author":"Xiang","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"R204-20250614","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(95)01415-2","article-title":"Endotoxin produces a depressive-like episode in rats.","volume":"711","author":"Yirmiya","year":"1996","journal-title":"Brain Res"},{"key":"R205-20250614","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbi.2010.10.015","article-title":"Immune modulation of learning, memory, neural plasticity and neurogenesis.","volume":"25","author":"Yirmiya","year":"2011","journal-title":"Brain Behav Immun"},{"key":"R206-20250614","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jad.2014.07.032","article-title":"A review of the relationship between proinflammatory cytokines and major depressive disorder.","volume":"169","author":"Young","year":"2014","journal-title":"J Affect Disord"},{"key":"R207-20250614","doi-asserted-by":"crossref","first-page":"15769","DOI":"10.1073\/pnas.95.26.15769","article-title":"Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.","volume":"95","author":"Yrj\u00e4nheikki","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R208-20250614","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbr.2019.01.045","article-title":"Minocycline ameliorates anxiety-related self-grooming behaviors and alters hippocampal neuroinflammation, GABA and serum cholesterol levels in female Sprague-Dawley rats subjected to chronic unpredictable mild stress.","volume":"363","author":"Zhang","year":"2019","journal-title":"Behav Brain Res"},{"key":"R209-20250614","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/0269881119858286","article-title":"Adjunctive minocycline for major mental disorders: a systematic review.","volume":"33","author":"Zheng","year":"2019","journal-title":"J Psychopharmacol"},{"key":"R210-20250614","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbi.2014.01.017","article-title":"Neonatal intrahippocampal injection of lipopolysaccharide induces deficits in social behavior and prepulse inhibition and microglial activation in rats: implication for a new schizophrenia animal model.","volume":"38","author":"Zhu","year":"2014","journal-title":"Brain Behav Immun"},{"key":"R211-20250614","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.psychres.2014.06.046","article-title":"Minocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic-polyribocytidilic acid.","volume":"219","author":"Zhu","year":"2014","journal-title":"Psychiatry Res"},{"key":"R212-20250614","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pnpbp.2010.04.011","article-title":"Glucocorticoids, cytokines and brain abnormalities in depression.","volume":"35","author":"Zunszain","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:03:18Z","timestamp":1749938598000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":219,"journal-issue":{"issue":"2&3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000585","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,15]]}}}